Item 7.01. Regulation FD Disclosure.

On November 14, 2012, Sucampo Pharmaceuticals, Inc. ("the Company") will make a corporate update presentation with one-on-one meetings in San Francisco, California. On November 15, 2012, the Company will make the same corporate update presentation at an investor conference in Phoenix, Arizona at the 2012 Credit Suisse Healthcare Conference. Both meetings will include written communication comprised of slides. The slides from the presentation are being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01 and Exhibit 99.1 to this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 The corporate update presentation slides dated November 14, 2012.

---